In this regard, abnormalities in coagulation parameters, namely fibrinogen, D-dimers, fibrin degradation product (FDP), and prothrombin time, were found in patients with severe forms of COVID-19 and have been significantly associated with increased mortality [51,52]. This evidence concerns the gene F2 and COVID-19.